Package 65162-956-09

{"route": ["ORAL"], "spl_id": "40e5eebb-7577-4c9e-bf1d-f511b8cb4d33", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0365162958034", "0365162986037", "0365162949032", "0365162990034", "0365162956030"], "unii": ["U3H27498KS"], "rxcui": ["850087", "850091", "900156", "900164", "1098608", "1146690"], "spl_set_id": ["0833d3df-2df1-4abd-abe0-7fb2c0253c80"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162-956-03)", "package_ndc": "65162-956-03", "marketing_start_date": "20181130"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162-956-09)", "package_ndc": "65162-956-09", "marketing_start_date": "20181130"}], "brand_name": "Lamotrigine", "product_id": "65162-956_40e5eebb-7577-4c9e-bf1d-f511b8cb4d33", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "65162-956", "generic_name": "Lamotrigine", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "50 mg/1"}], "application_number": "ANDA207497", "marketing_category": "ANDA", "marketing_start_date": "20181130", "listing_expiration_date": "20261231"}